{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:20:11Z","timestamp":1785115211906,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI14C0175"],"award-info":[{"award-number":["HI14C0175"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jcms.2021.02.023","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T02:19:24Z","timestamp":1614305964000},"page":"719-725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effect and timing of parathyroid hormone analog administration for preventing medication-related osteonecrosis of the jaws in a murine model"],"prefix":"10.1016","volume":"49","author":[{"given":"Junho","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyu-Jo","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngjae","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Suk","family":"Jue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Al-Nawas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9620-4814","authenticated-orcid":false,"given":"Yong-Dae","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jcms.2021.02.023_bib1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jcms.2020.07.012","article-title":"Surgical treatment of advanced medication-related osteonecrosis of the jaws: comparison of soft tissue closure techniques and evaluation of side effects","volume":"48","author":"Ahrenbog","year":"2020","journal-title":"J\u00a0Craniomaxillofac Surg"},{"issue":"9","key":"10.1016\/j.jcms.2021.02.023_bib2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jcms.2018.05.046","article-title":"Osteonecrosis of the jaw in patients treated with denosumab: a multicenter case series","volume":"46","author":"Aljohani","year":"2018","journal-title":"J\u00a0Craniomaxillofac Surg"},{"issue":"6","key":"10.1016\/j.jcms.2021.02.023_bib3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jcms.2013.11.005","article-title":"Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats","volume":"42","author":"Barba-Recreo","year":"2014","journal-title":"J\u00a0Craniomaxillofac Surg"},{"issue":"2","key":"10.1016\/j.jcms.2021.02.023_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jcms.2018.08.011","article-title":"Influence of induced infection in medication-related osteonecrosis of the jaw development after tooth extraction: a study in rats","volume":"47","author":"Bolette","year":"2019","journal-title":"J\u00a0Craniomaxillofac Surg"},{"issue":"11","key":"10.1016\/j.jcms.2021.02.023_bib5","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jcms.2020.09.008","article-title":"Pentoxifylline and tocopherol protocol to treat medication-related osteonecrosis of the jaw: a systematic literature review","volume":"48","author":"Cavalcante","year":"2020","journal-title":"J\u00a0Craniomaxillofac Surg"},{"issue":"2","key":"10.1016\/j.jcms.2021.02.023_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/03008207.2017.1290085","article-title":"Osteoblast-osteoclast interactions","volume":"59","author":"Chen","year":"2018","journal-title":"Connect Tissue Res"},{"issue":"25","key":"10.1016\/j.jcms.2021.02.023_bib7","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMc1002684","article-title":"Teriparatide therapy for alendronate-associated osteonecrosis of the jaw","volume":"363","author":"Cheung","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.jcms.2021.02.023_bib8","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.ijom.2013.05.001","article-title":"The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study","volume":"42","author":"Dayisoylu","year":"2013","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.jcms.2021.02.023_bib9","first-page":"222","article-title":"Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw associated with dental implants","volume":"24","author":"Doh","year":"2015","journal-title":"Implant Dent"},{"issue":"1\u20132","key":"10.1016\/j.jcms.2021.02.023_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/odi.12764","article-title":"Medication-related osteonecrosis of the jaw: surgical or non-surgical treatment?","volume":"24","author":"Favia","year":"2018","journal-title":"Oral Dis"},{"issue":"1","key":"10.1016\/j.jcms.2021.02.023_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00774-016-0736-0","article-title":"Comparison of parathyroid hormone and strontium ranelate in combination with whole-body vibration in a rat model of osteoporosis","volume":"35","author":"Hoffmann","year":"2017","journal-title":"J\u00a0Bone Miner Metab"},{"issue":"1","key":"10.1016\/j.jcms.2021.02.023_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40902-015-0020-6","article-title":"Development of animal model for Bisphosphonates-related osteonecrosis of the jaw (BRONJ)","volume":"37","author":"Jang","year":"2015","journal-title":"Maxillofac Plast Reconstr Surg"},{"key":"10.1016\/j.jcms.2021.02.023_bib13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.yrtph.2017.04.001","article-title":"Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1-34)","volume":"86","author":"Jolette","year":"2017","journal-title":"Regul Toxicol Pharmacol"},{"issue":"12","key":"10.1016\/j.jcms.2021.02.023_bib14","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/jbmr.3237","article-title":"Short-term teriparatide and recombinant human bone morphogenetic protein-2 for regenerative approach to medication-related osteonecrosis of the jaw: a preliminary study","volume":"32","author":"Jung","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"issue":"12","key":"10.1016\/j.jcms.2021.02.023_bib15","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.ijom.2015.07.018","article-title":"Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings","volume":"44","author":"Kakehashi","year":"2015","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"1","key":"10.1016\/j.jcms.2021.02.023_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.joms.2015.07.005","article-title":"Histopathological effects of teriparatide in medication-related osteonecrosis of the jaw: an animal study","volume":"74","author":"Keskinruzgar","year":"2016","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.jcms.2021.02.023_bib17","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00198-013-2570-8","article-title":"Early effects of parathyroid hormone on bisphosphonate\/steroid-associated compromised osseous wound healing","volume":"25","author":"Kuroshima","year":"2014","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.jcms.2021.02.023_bib18","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1007\/s00198-011-1882-9","article-title":"Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws","volume":"23","author":"Kwon","year":"2012","journal-title":"Osteoporos Int"},{"issue":"9","key":"10.1016\/j.jcms.2021.02.023_bib19","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hed.21380","article-title":"Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy","volume":"33","author":"Lee","year":"2011","journal-title":"Head Neck"},{"issue":"49","key":"10.1016\/j.jcms.2021.02.023_bib20","doi-asserted-by":"crossref","first-page":"38014","DOI":"10.1074\/jbc.M110.142141","article-title":"Parathyroid hormone activation of matrix metalloproteinase-13 transcription requires the histone acetyltransferase activity of p300 and PCAF and p300-dependent acetylation of PCAF","volume":"285","author":"Lee","year":"2010","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.jcms.2021.02.023_bib21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2165\/11585470-000000000-00000","article-title":"Safety of long-term bisphosphonate therapy for the management of osteoporosis","volume":"71","author":"Lewiecki","year":"2011","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.jcms.2021.02.023_bib22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1152\/physrev.00031.2015","article-title":"Parathyroid hormone-related protein, its regulation of cartilage and bone development, and role in treating bone diseases","volume":"96","author":"Martin","year":"2016","journal-title":"Physiol Rev"},{"issue":"7","key":"10.1016\/j.jcms.2021.02.023_bib23","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jcms.2019.03.002","article-title":"Medication-related osteonecrosis of the jaw in a minipig model: parameters for developing a macroscopic, radiological, and microscopic grading scheme","volume":"47","author":"Nowicki","year":"2019","journal-title":"J\u00a0Craniomaxillofac Surg"},{"issue":"3","key":"10.1016\/j.jcms.2021.02.023_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.tem.2015.01.004","article-title":"Anabolic effects of PTH and the \u2019anabolic window","volume":"26","author":"Pazianas","year":"2015","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.jcms.2021.02.023_bib25","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1007\/s00198-013-2385-7","article-title":"Effect of intermittent PTH (1-34) on posterolateral spinal fusion with iliac crest bone graft in an ovariectomized rat model","volume":"24","author":"Qiu","year":"2013","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.jcms.2021.02.023_bib26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bone.2010.10.003","article-title":"Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model","volume":"48","author":"Reynolds","year":"2011","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.jcms.2021.02.023_bib27","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.jcms.2021.02.023_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.tripleo.2009.10.011","article-title":"Jaw bone changes in rats after treatment with zoledronate and pamidronate","volume":"109","author":"Senel","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"10.1016\/j.jcms.2021.02.023_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/1061186X.2014.950668","article-title":"The critical role of bisphosphonates to target bone cancer metastasis: an overview","volume":"23","author":"Singh","year":"2015","journal-title":"J\u00a0Drug Target"},{"issue":"2","key":"10.1016\/j.jcms.2021.02.023_bib30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/bcp.13455","article-title":"Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism - translating the pharmacology","volume":"84","author":"Tay","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.jcms.2021.02.023_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jcms.2020.02.017","article-title":"Medication-related osteonecrosis of the jaw (MRONJ) stage III: conservative and conservative surgical approaches versus an aggressive surgical intervention: a systematic review","volume":"48","author":"Vanpoecke","year":"2020","journal-title":"J\u00a0Craniomaxillofac Surg"},{"issue":"3","key":"10.1016\/j.jcms.2021.02.023_bib32","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jcms.2017.12.027","article-title":"Effect of different doses and durations of teriparatide therapy on resolution of medication-related osteonecrosis of the jaw: a randomized, controlled preclinical study in rats","volume":"46","author":"Zandi","year":"2018","journal-title":"J\u00a0Craniomaxillofac Surg"}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518221000809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518221000809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:43:28Z","timestamp":1760885008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010518221000809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1010518221000809"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2021.02.023","relation":{},"ISSN":["1010-5182"],"issn-type":[{"value":"1010-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect and timing of parathyroid hormone analog administration for preventing medication-related osteonecrosis of the jaws in a murine model","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2021.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}